Rank | Gene Set | Z-score |
---|---|---|
1 | response to peptidoglycan (GO:0032494) | 5.68092736 |
2 | positive regulation by symbiont of host defense response (GO:0052509) | 5.11477378 |
3 | modulation by symbiont of host defense response (GO:0052031) | 5.11477378 |
4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.11477378 |
5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.11477378 |
6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.11477378 |
7 | modulation by symbiont of host immune response (GO:0052553) | 5.11477378 |
8 | respiratory burst (GO:0045730) | 4.93356263 |
9 | neutrophil activation involved in immune response (GO:0002283) | 4.91522065 |
10 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.81873421 |
11 | reactive oxygen species biosynthetic process (GO:1903409) | 4.46312128 |
12 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.98705190 |
13 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.91228861 |
14 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.88523421 |
15 | response to host immune response (GO:0052572) | 3.81145243 |
16 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.81145243 |
17 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.80602612 |
18 | macrophage activation involved in immune response (GO:0002281) | 3.76897838 |
19 | negative regulation of cell killing (GO:0031342) | 3.71943355 |
20 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.71943355 |
21 | superoxide anion generation (GO:0042554) | 3.71370786 |
22 | positive regulation of interferon-alpha production (GO:0032727) | 3.67685975 |
23 | granulocyte activation (GO:0036230) | 3.65882193 |
24 | low-density lipoprotein particle clearance (GO:0034383) | 3.64757004 |
25 | leukocyte aggregation (GO:0070486) | 3.64311775 |
26 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.63837329 |
27 | immunoglobulin mediated immune response (GO:0016064) | 3.59249800 |
28 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.54949366 |
29 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.53561182 |
30 | response to fungus (GO:0009620) | 3.50293949 |
31 | regulation of interferon-alpha production (GO:0032647) | 3.48121621 |
32 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.46508836 |
33 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.46508836 |
34 | neutrophil activation (GO:0042119) | 3.45276607 |
35 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.42443834 |
36 | detection of other organism (GO:0098543) | 3.40576154 |
37 | regulation of gamma-delta T cell activation (GO:0046643) | 3.36441351 |
38 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.35919318 |
39 | response to host (GO:0075136) | 3.35919318 |
40 | response to host defenses (GO:0052200) | 3.35919318 |
41 | cellular extravasation (GO:0045123) | 3.34491649 |
42 | response to muramyl dipeptide (GO:0032495) | 3.34304473 |
43 | B cell mediated immunity (GO:0019724) | 3.33010719 |
44 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.31620477 |
45 | positive regulation of B cell differentiation (GO:0045579) | 3.28706179 |
46 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.28279997 |
47 | response to protozoan (GO:0001562) | 3.27091401 |
48 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.24715515 |
49 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.22970516 |
50 | germinal center formation (GO:0002467) | 3.22482502 |
51 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.22005527 |
52 | defense response to protozoan (GO:0042832) | 3.21262949 |
53 | detection of bacterium (GO:0016045) | 3.20092212 |
54 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.17870381 |
55 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.17803209 |
56 | regulation of chemokine biosynthetic process (GO:0045073) | 3.16822207 |
57 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.15238674 |
58 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.10915124 |
59 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.10875770 |
60 | regulation of platelet activation (GO:0010543) | 3.08479537 |
61 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.07438384 |
62 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.04185633 |
63 | myeloid cell activation involved in immune response (GO:0002275) | 3.04148373 |
64 | plasma lipoprotein particle clearance (GO:0034381) | 3.02669873 |
65 | killing of cells of other organism (GO:0031640) | 3.02415471 |
66 | disruption of cells of other organism (GO:0044364) | 3.02415471 |
67 | leukocyte degranulation (GO:0043299) | 3.01034308 |
68 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.00625172 |
69 | thrombin receptor signaling pathway (GO:0070493) | 3.00267454 |
70 | neutrophil mediated immunity (GO:0002446) | 2.97864145 |
71 | negative regulation of T cell mediated immunity (GO:0002710) | 2.97457716 |
72 | phagosome maturation (GO:0090382) | 2.97157881 |
73 | positive regulation of type 2 immune response (GO:0002830) | 2.97049274 |
74 | negative regulation of interleukin-12 production (GO:0032695) | 2.95785483 |
75 | T-helper 1 type immune response (GO:0042088) | 2.94987724 |
76 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.94306746 |
77 | negative regulation of growth of symbiont in host (GO:0044130) | 2.94082924 |
78 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.94082924 |
79 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.94082924 |
80 | regulation of growth of symbiont in host (GO:0044126) | 2.94082924 |
81 | regulation of podosome assembly (GO:0071801) | 2.93435097 |
82 | regulation of interleukin-12 production (GO:0032655) | 2.92302778 |
83 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.88890458 |
84 | detection of molecule of bacterial origin (GO:0032490) | 2.84797887 |
85 | regulation of integrin activation (GO:0033623) | 2.84671913 |
86 | neutrophil chemotaxis (GO:0030593) | 2.82806904 |
87 | regulation of vitamin metabolic process (GO:0030656) | 2.82231141 |
88 | defense response to fungus (GO:0050832) | 2.82115136 |
89 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.81656730 |
90 | T cell migration (GO:0072678) | 2.80605154 |
91 | regulation of mast cell degranulation (GO:0043304) | 2.80211576 |
92 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.79511672 |
93 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.78560184 |
94 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.78402468 |
95 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.77890431 |
96 | negative regulation of interleukin-17 production (GO:0032700) | 2.77848565 |
97 | positive regulation of interleukin-10 production (GO:0032733) | 2.77553415 |
98 | detection of external biotic stimulus (GO:0098581) | 2.76742052 |
99 | regulation of chronic inflammatory response (GO:0002676) | 2.76034828 |
100 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.75049097 |
101 | positive regulation of mast cell degranulation (GO:0043306) | 2.75049097 |
102 | positive regulation of antigen processing and presentation (GO:0002579) | 2.74822419 |
103 | neutrophil migration (GO:1990266) | 2.74227721 |
104 | positive regulation of interleukin-6 production (GO:0032755) | 2.74085291 |
105 | regulation of platelet aggregation (GO:0090330) | 2.73530176 |
106 | regulation of interleukin-17 production (GO:0032660) | 2.73443759 |
107 | positive regulation of mast cell activation (GO:0033005) | 2.72820844 |
108 | myeloid leukocyte activation (GO:0002274) | 2.71720746 |
109 | regulation of antigen processing and presentation (GO:0002577) | 2.71036338 |
110 | positive regulation of interleukin-17 production (GO:0032740) | 2.71007880 |
111 | positive regulation of B cell mediated immunity (GO:0002714) | 2.70845897 |
112 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.70719040 |
113 | positive regulation of interferon-beta production (GO:0032728) | 2.66843132 |
114 | regulation of mast cell activation (GO:0033003) | 2.64316748 |
115 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.63929078 |
116 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.63929078 |
117 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.63188220 |
118 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.63007795 |
119 | regulation of triglyceride catabolic process (GO:0010896) | 2.62947293 |
120 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.60887329 |
121 | leukocyte mediated cytotoxicity (GO:0001909) | 2.60632933 |
122 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.60468058 |
123 | natural killer cell mediated immunity (GO:0002228) | 2.60468058 |
124 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.59411342 |
125 | cellular response to type I interferon (GO:0071357) | 2.58552736 |
126 | type I interferon signaling pathway (GO:0060337) | 2.58552736 |
127 | regulation of mononuclear cell migration (GO:0071675) | 2.58257704 |
128 | cell killing (GO:0001906) | 2.58041664 |
129 | response to type I interferon (GO:0034340) | 2.56985365 |
130 | microglial cell activation (GO:0001774) | 2.56290030 |
131 | negative regulation of mast cell activation (GO:0033004) | 2.55616795 |
132 | cofactor catabolic process (GO:0051187) | 2.54215356 |
133 | regulation of leukocyte degranulation (GO:0043300) | 2.54166962 |
134 | macrophage activation (GO:0042116) | 2.53205664 |
135 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.52935213 |
136 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.52674768 |
137 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.52551943 |
138 | positive regulation of leukocyte degranulation (GO:0043302) | 2.51807617 |
139 | leukotriene metabolic process (GO:0006691) | 2.50982341 |
140 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.49532552 |
141 | skeletal muscle adaptation (GO:0043501) | 2.49309296 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.17243229 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.87791091 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.55490145 |
4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.85327296 |
5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.77717762 |
6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.73290783 |
7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.48719914 |
8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.39966798 |
9 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.16570735 |
10 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.02888463 |
11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.90518784 |
12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.77870285 |
13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.68130828 |
14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.66320944 |
15 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.57011313 |
16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.47339106 |
17 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.33794061 |
18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.17777220 |
19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.08465489 |
20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.05548942 |
21 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.99683584 |
22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.97112093 |
23 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.89615442 |
24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.81417013 |
25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.79095039 |
26 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.77935472 |
27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.75537358 |
28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.74447576 |
29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.73883987 |
30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73583860 |
31 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.69905272 |
32 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.69447732 |
33 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.60897594 |
34 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.55137093 |
35 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.54364428 |
36 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.51189945 |
37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50813325 |
38 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.49719584 |
39 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.46620344 |
40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.46076776 |
41 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.43290212 |
42 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41388466 |
43 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.40330398 |
44 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.39005390 |
45 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.38879355 |
46 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.37464603 |
47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30735565 |
48 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.29542260 |
49 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28964279 |
50 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26841697 |
51 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.25313723 |
52 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.23701728 |
53 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.23598360 |
54 | MYC_22102868_ChIP-Seq_BL_Human | 1.21385562 |
55 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21265070 |
56 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.21150488 |
57 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20756364 |
58 | MAF_26560356_Chip-Seq_TH1_Human | 1.19522692 |
59 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.18691903 |
60 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18076290 |
61 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17430343 |
62 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.17097083 |
63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15676203 |
64 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15637871 |
65 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.15555354 |
66 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.15555354 |
67 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15386818 |
68 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15195853 |
69 | MYB_26560356_Chip-Seq_TH2_Human | 1.12370680 |
70 | MAF_26560356_Chip-Seq_TH2_Human | 1.11282320 |
71 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10898354 |
72 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10730891 |
73 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10553947 |
74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09656303 |
75 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.09077496 |
76 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.07531197 |
77 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.06548137 |
78 | GATA3_26560356_Chip-Seq_TH2_Human | 1.06235043 |
79 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.04651013 |
80 | GATA2_19941826_ChIP-Seq_K562_Human | 1.04265912 |
81 | GATA1_19941826_ChIP-Seq_K562_Human | 1.04102412 |
82 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02820956 |
83 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.00584826 |
84 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00153229 |
85 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.99315367 |
86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99223010 |
87 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.97697357 |
88 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96746370 |
89 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96607191 |
90 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.95589417 |
91 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.95247394 |
92 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94592855 |
93 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.94484752 |
94 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.93507790 |
95 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.93481229 |
96 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.92979004 |
97 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.90522620 |
98 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.89934264 |
99 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.89074677 |
100 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85040050 |
101 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.85021055 |
102 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84721194 |
103 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.84611022 |
104 | MYB_26560356_Chip-Seq_TH1_Human | 0.84571419 |
105 | GATA1_22025678_ChIP-Seq_K562_Human | 0.83743211 |
106 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.83616727 |
107 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82628223 |
108 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.82363260 |
109 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.78363214 |
110 | UTX_26944678_Chip-Seq_JUKART_Human | 0.77820340 |
111 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.77409412 |
112 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.77124293 |
113 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.77045528 |
114 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.76871192 |
115 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.76737164 |
116 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.76356487 |
117 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73948961 |
118 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.72307030 |
119 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.71320512 |
120 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.70590189 |
121 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.70445533 |
122 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69507651 |
123 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.69240036 |
124 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.69201338 |
125 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.68570526 |
126 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67062379 |
127 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.66034305 |
128 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.65829309 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003436_decreased_susceptibility_to | 3.86340493 |
2 | MP0003303_peritoneal_inflammation | 3.53532739 |
3 | MP0009785_altered_susceptibility_to | 3.40860894 |
4 | MP0001835_abnormal_antigen_presentation | 3.06285570 |
5 | MP0002419_abnormal_innate_immunity | 3.00463389 |
6 | MP0005360_urolithiasis | 2.83173506 |
7 | MP0002148_abnormal_hypersensitivity_rea | 2.79322946 |
8 | MP0009840_abnormal_foam_cell | 2.76793575 |
9 | MP0006082_CNS_inflammation | 2.69463884 |
10 | MP0005025_abnormal_response_to | 2.63899317 |
11 | * MP0005000_abnormal_immune_tolerance | 2.57126214 |
12 | MP0002139_abnormal_hepatobiliary_system | 2.53496305 |
13 | MP0003724_increased_susceptibility_to | 2.52472585 |
14 | MP0005058_abnormal_lysosome_morphology | 2.42658111 |
15 | MP0004510_myositis | 2.36204469 |
16 | MP0003806_abnormal_nucleotide_metabolis | 2.23026023 |
17 | MP0001790_abnormal_immune_system | 2.22658914 |
18 | MP0005387_immune_system_phenotype | 2.22658914 |
19 | MP0008004_abnormal_stomach_pH | 2.22411075 |
20 | * MP0001533_abnormal_skeleton_physiology | 2.01476589 |
21 | MP0003646_muscle_fatigue | 2.01170661 |
22 | MP0009278_abnormal_bone_marrow | 1.98341536 |
23 | MP0000685_abnormal_immune_system | 1.97975180 |
24 | * MP0002452_abnormal_antigen_presenting | 1.93091309 |
25 | MP0005464_abnormal_platelet_physiology | 1.91588537 |
26 | * MP0002723_abnormal_immune_serum | 1.85240559 |
27 | MP0009764_decreased_sensitivity_to | 1.85199238 |
28 | * MP0001800_abnormal_humoral_immune | 1.84667436 |
29 | MP0001853_heart_inflammation | 1.83431935 |
30 | MP0003191_abnormal_cellular_cholesterol | 1.83279391 |
31 | MP0000343_altered_response_to | 1.80645630 |
32 | MP0003075_altered_response_to | 1.79399355 |
33 | MP0003172_abnormal_lysosome_physiology | 1.76323249 |
34 | MP0003656_abnormal_erythrocyte_physiolo | 1.75125947 |
35 | MP0005085_abnormal_gallbladder_physiolo | 1.74743017 |
36 | MP0008469_abnormal_protein_level | 1.74272508 |
37 | * MP0004947_skin_inflammation | 1.73941524 |
38 | MP0003195_calcinosis | 1.73521865 |
39 | MP0003183_abnormal_peptide_metabolism | 1.71741784 |
40 | * MP0001845_abnormal_inflammatory_respons | 1.70809489 |
41 | MP0000604_amyloidosis | 1.62563947 |
42 | MP0005083_abnormal_biliary_tract | 1.62118728 |
43 | * MP0001819_abnormal_immune_cell | 1.60466591 |
44 | MP0000465_gastrointestinal_hemorrhage | 1.59711055 |
45 | MP0005451_abnormal_body_composition | 1.58103964 |
46 | * MP0002420_abnormal_adaptive_immunity | 1.57950255 |
47 | MP0005365_abnormal_bile_salt | 1.57688606 |
48 | MP0003186_abnormal_redox_activity | 1.57073489 |
49 | MP0005671_abnormal_response_to | 1.53322780 |
50 | MP0008875_abnormal_xenobiotic_pharmacok | 1.49065052 |
51 | MP0002405_respiratory_system_inflammati | 1.47758661 |
52 | MP0008260_abnormal_autophagy | 1.37973177 |
53 | MP0010155_abnormal_intestine_physiology | 1.36188472 |
54 | MP0003763_abnormal_thymus_physiology | 1.33266460 |
55 | MP0006054_spinal_hemorrhage | 1.29662367 |
56 | MP0010329_abnormal_lipoprotein_level | 1.24246867 |
57 | MP0005167_abnormal_blood-brain_barrier | 1.23805478 |
58 | MP0005166_decreased_susceptibility_to | 1.23682917 |
59 | MP0005310_abnormal_salivary_gland | 1.23329229 |
60 | MP0003252_abnormal_bile_duct | 1.22141283 |
61 | MP0001851_eye_inflammation | 1.21942400 |
62 | MP0003300_gastrointestinal_ulcer | 1.20147841 |
63 | MP0000609_abnormal_liver_physiology | 1.19490750 |
64 | MP0003690_abnormal_glial_cell | 1.18721890 |
65 | MP0009763_increased_sensitivity_to | 1.17989694 |
66 | MP0000920_abnormal_myelination | 1.17553684 |
67 | MP0003448_altered_tumor_morphology | 1.16947291 |
68 | MP0005397_hematopoietic_system_phenotyp | 1.11584890 |
69 | MP0001545_abnormal_hematopoietic_system | 1.11584890 |
70 | MP0005319_abnormal_enzyme/_coenzyme | 1.11152939 |
71 | MP0004808_abnormal_hematopoietic_stem | 1.11122566 |
72 | MP0000716_abnormal_immune_system | 1.07662265 |
73 | MP0004130_abnormal_muscle_cell | 1.07599451 |
74 | MP0002998_abnormal_bone_remodeling | 1.05688178 |
75 | MP0009333_abnormal_splenocyte_physiolog | 1.05500852 |
76 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.04768770 |
77 | MP0002118_abnormal_lipid_homeostasis | 1.00060689 |
78 | MP0001663_abnormal_digestive_system | 0.99890429 |
79 | MP0002132_abnormal_respiratory_system | 0.93969904 |
80 | MP0001666_abnormal_nutrient_absorption | 0.93861283 |
81 | MP0003453_abnormal_keratinocyte_physiol | 0.90422426 |
82 | MP0000858_altered_metastatic_potential | 0.88202600 |
83 | MP0000749_muscle_degeneration | 0.87581455 |
84 | MP0005332_abnormal_amino_acid | 0.86271513 |
85 | MP0003329_amyloid_beta_deposits | 0.86144830 |
86 | MP0002933_joint_inflammation | 0.85826326 |
87 | MP0005164_abnormal_response_to | 0.85585372 |
88 | MP0004883_abnormal_blood_vessel | 0.84904068 |
89 | MP0002398_abnormal_bone_marrow | 0.84829940 |
90 | MP0002837_dystrophic_cardiac_calcinosis | 0.83618628 |
91 | MP0000703_abnormal_thymus_morphology | 0.82176756 |
92 | * MP0002429_abnormal_blood_cell | 0.81853008 |
93 | MP0003221_abnormal_cardiomyocyte_apopto | 0.81498792 |
94 | MP0002006_tumorigenesis | 0.81040974 |
95 | * MP0005390_skeleton_phenotype | 0.78340347 |
96 | MP0003828_pulmonary_edema | 0.78170561 |
97 | MP0002396_abnormal_hematopoietic_system | 0.78121684 |
98 | MP0003566_abnormal_cell_adhesion | 0.78053960 |
99 | * MP0000689_abnormal_spleen_morphology | 0.77261007 |
100 | MP0008874_decreased_physiological_sensi | 0.75832548 |
101 | MP0005165_increased_susceptibility_to | 0.75813059 |
102 | MP0003866_abnormal_defecation | 0.75079014 |
103 | MP0002138_abnormal_hepatobiliary_system | 0.74911945 |
104 | MP0005535_abnormal_body_temperature | 0.72305941 |
105 | MP0009643_abnormal_urine_homeostasis | 0.70216352 |
106 | MP0002254_reproductive_system_inflammat | 0.70113519 |
107 | MP0000249_abnormal_blood_vessel | 0.67772443 |
108 | MP0002332_abnormal_exercise_endurance | 0.67187303 |
109 | MP0003795_abnormal_bone_structure | 0.66770710 |
110 | MP0000015_abnormal_ear_pigmentation | 0.65430664 |
111 | * MP0002722_abnormal_immune_system | 0.65320638 |
112 | MP0005076_abnormal_cell_differentiation | 0.64719386 |
113 | MP0001873_stomach_inflammation | 0.64657353 |
114 | MP0009765_abnormal_xenobiotic_induced | 0.64593076 |
115 | MP0001764_abnormal_homeostasis | 0.64550988 |
116 | MP0004858_abnormal_nervous_system | 0.64467199 |
117 | MP0002106_abnormal_muscle_physiology | 0.63838531 |
118 | MP0005647_abnormal_sex_gland | 0.55345306 |
119 | MP0002277_abnormal_respiratory_mucosa | 0.54976246 |
120 | MP0005381_digestive/alimentary_phenotyp | 0.54681653 |
121 | MP0003091_abnormal_cell_migration | 0.52741580 |
122 | MP0003045_fibrosis | 0.52691402 |
123 | MP0002019_abnormal_tumor_incidence | 0.52646928 |
124 | MP0005023_abnormal_wound_healing | 0.50028771 |
125 | MP0002877_abnormal_melanocyte_morpholog | 0.49718724 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 7.00012039 |
2 | Recurrent abscess formation (HP:0002722) | 6.74732989 |
3 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.67336826 |
4 | Recurrent bacterial skin infections (HP:0005406) | 6.19633605 |
5 | Prolonged bleeding time (HP:0003010) | 5.24549214 |
6 | Abnormality of macrophages (HP:0004311) | 4.90236146 |
7 | Systemic lupus erythematosus (HP:0002725) | 4.28169047 |
8 | Epistaxis (HP:0000421) | 4.03984017 |
9 | Mediastinal lymphadenopathy (HP:0100721) | 4.03435241 |
10 | Gingivitis (HP:0000230) | 3.96065610 |
11 | Orchitis (HP:0100796) | 3.94905547 |
12 | Retrobulbar optic neuritis (HP:0100654) | 3.82711578 |
13 | Optic neuritis (HP:0100653) | 3.82711578 |
14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.74956610 |
15 | Recurrent skin infections (HP:0001581) | 3.64536208 |
16 | Abnormal platelet volume (HP:0011876) | 3.63736862 |
17 | Axonal loss (HP:0003447) | 3.62656292 |
18 | Myositis (HP:0100614) | 3.58905270 |
19 | Stomatitis (HP:0010280) | 3.56325490 |
20 | Obstructive lung disease (HP:0006536) | 3.50622301 |
21 | Chronic obstructive pulmonary disease (HP:0006510) | 3.50622301 |
22 | Increased mean platelet volume (HP:0011877) | 3.44844493 |
23 | Spontaneous hematomas (HP:0007420) | 3.38389189 |
24 | Menorrhagia (HP:0000132) | 3.10153118 |
25 | Vacuolated lymphocytes (HP:0001922) | 3.09982015 |
26 | Encephalitis (HP:0002383) | 3.08294577 |
27 | Autoimmune thrombocytopenia (HP:0001973) | 3.07702576 |
28 | Urticaria (HP:0001025) | 3.06537441 |
29 | Increased IgM level (HP:0003496) | 2.99059959 |
30 | Increased cerebral lipofuscin (HP:0011813) | 2.93063410 |
31 | Recurrent fungal infections (HP:0002841) | 2.88536708 |
32 | Abnormal platelet function (HP:0011869) | 2.88121814 |
33 | Impaired platelet aggregation (HP:0003540) | 2.88121814 |
34 | Autoimmune hemolytic anemia (HP:0001890) | 2.85284131 |
35 | Vasculitis (HP:0002633) | 2.85099724 |
36 | Muscle fiber inclusion bodies (HP:0100299) | 2.82663081 |
37 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.78631617 |
38 | Joint hemorrhage (HP:0005261) | 2.78157941 |
39 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.74495762 |
40 | Amyloidosis (HP:0011034) | 2.74300427 |
41 | Xanthomatosis (HP:0000991) | 2.72118036 |
42 | Hemoptysis (HP:0002105) | 2.71678551 |
43 | T lymphocytopenia (HP:0005403) | 2.71639553 |
44 | Cellulitis (HP:0100658) | 2.70397940 |
45 | Glomerulonephritis (HP:0000099) | 2.67911655 |
46 | Disinhibition (HP:0000734) | 2.65915112 |
47 | Nemaline bodies (HP:0003798) | 2.65387688 |
48 | Abnormality of T cell number (HP:0011839) | 2.63838504 |
49 | Gastrointestinal infarctions (HP:0005244) | 2.63716670 |
50 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.61694770 |
51 | Recurrent cutaneous fungal infections (HP:0011370) | 2.61694770 |
52 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.59711978 |
53 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.56936422 |
54 | Chest pain (HP:0100749) | 2.55570402 |
55 | Peritonitis (HP:0002586) | 2.54224843 |
56 | Myocardial infarction (HP:0001658) | 2.52632244 |
57 | Keratoconjunctivitis sicca (HP:0001097) | 2.50034477 |
58 | Episodic fever (HP:0001954) | 2.46923335 |
59 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.44501596 |
60 | Ulnar deviation of the wrist (HP:0003049) | 2.42182412 |
61 | Gingival bleeding (HP:0000225) | 2.42153731 |
62 | Exercise-induced muscle cramps (HP:0003710) | 2.41391057 |
63 | Vertigo (HP:0002321) | 2.40570304 |
64 | Keratoconjunctivitis (HP:0001096) | 2.36096180 |
65 | Periodontitis (HP:0000704) | 2.35424313 |
66 | Pulmonary infiltrates (HP:0002113) | 2.34263162 |
67 | Meningitis (HP:0001287) | 2.31919375 |
68 | Joint swelling (HP:0001386) | 2.31337744 |
69 | Deep venous thrombosis (HP:0002625) | 2.29730997 |
70 | Thick nail (HP:0001805) | 2.29285909 |
71 | Abnormality of the common coagulation pathway (HP:0010990) | 2.28297040 |
72 | Hepatosplenomegaly (HP:0001433) | 2.28106319 |
73 | Polyneuropathy (HP:0001271) | 2.27603105 |
74 | Tetraparesis (HP:0002273) | 2.25976152 |
75 | Recurrent viral infections (HP:0004429) | 2.25899358 |
76 | Granulocytopenia (HP:0001913) | 2.22416708 |
77 | Pustule (HP:0200039) | 2.21625348 |
78 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.20158689 |
79 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.19685498 |
80 | Osteomyelitis (HP:0002754) | 2.19681505 |
81 | Abnormality of T cells (HP:0002843) | 2.18069491 |
82 | Abnormality of complement system (HP:0005339) | 2.17990507 |
83 | Paralysis (HP:0003470) | 2.17863212 |
84 | Increased IgE level (HP:0003212) | 2.17746945 |
85 | Complement deficiency (HP:0004431) | 2.17431072 |
86 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.16465856 |
87 | Nephritis (HP:0000123) | 2.16042611 |
88 | Amaurosis fugax (HP:0100576) | 2.14579715 |
89 | Abnormality of glycolipid metabolism (HP:0010969) | 2.14263358 |
90 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.14263358 |
91 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.14263358 |
92 | Hypergammaglobulinemia (HP:0010702) | 2.14074809 |
93 | Basal ganglia calcification (HP:0002135) | 2.14000050 |
94 | Intrahepatic cholestasis (HP:0001406) | 2.12259514 |
95 | Recurrent pneumonia (HP:0006532) | 2.11685363 |
96 | Increased serum ferritin (HP:0003281) | 2.10056592 |
97 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.09629261 |
98 | Inflammation of the large intestine (HP:0002037) | 2.09440305 |
99 | Hypoglycemic coma (HP:0001325) | 2.08770221 |
100 | Exercise-induced myalgia (HP:0003738) | 2.08286585 |
101 | Arterial thrombosis (HP:0004420) | 2.07058609 |
102 | Mutism (HP:0002300) | 2.05579527 |
103 | Conjunctival telangiectasia (HP:0000524) | 2.05478188 |
104 | Prolonged partial thromboplastin time (HP:0003645) | 2.05293523 |
105 | Thrombocytosis (HP:0001894) | 2.04839445 |
106 | Abnormality of the prostate (HP:0008775) | 2.04595324 |
107 | Abnormality of iron homeostasis (HP:0011031) | 2.02929332 |
108 | Nausea (HP:0002018) | 2.02551605 |
109 | Thrombophlebitis (HP:0004418) | 2.02278438 |
110 | Leukocytosis (HP:0001974) | 2.02101822 |
111 | Muscle fiber splitting (HP:0003555) | 2.01960198 |
112 | Mucopolysacchariduria (HP:0008155) | 2.01874062 |
113 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.01874062 |
114 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.00529398 |
115 | Dysostosis multiplex (HP:0000943) | 2.00440596 |
116 | Purpura (HP:0000979) | 1.99920158 |
117 | Petechiae (HP:0000967) | 1.99826001 |
118 | Panhypogammaglobulinemia (HP:0003139) | 1.99152308 |
119 | Eosinophilia (HP:0001880) | 1.97563016 |
120 | Glomerulopathy (HP:0100820) | 1.96724570 |
121 | Hematochezia (HP:0002573) | 1.96282578 |
122 | Interstitial pulmonary disease (HP:0006530) | 1.95863871 |
123 | Hemorrhage of the eye (HP:0011885) | 1.95403491 |
124 | Polycythemia (HP:0001901) | 1.94934373 |
125 | Gastrointestinal inflammation (HP:0004386) | 1.94776457 |
126 | Abnormality of the pleura (HP:0002103) | 1.94607349 |
127 | Hypobetalipoproteinemia (HP:0003563) | 1.94503325 |
128 | Loss of speech (HP:0002371) | 1.94335550 |
129 | Chronic otitis media (HP:0000389) | 1.93419660 |
130 | Anorexia (HP:0002039) | 1.93401139 |
131 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.92332337 |
132 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.92332337 |
133 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.92332337 |
134 | Pulmonary embolism (HP:0002204) | 1.89463934 |
135 | Gangrene (HP:0100758) | 1.87811661 |
136 | Frequent falls (HP:0002359) | 1.85696274 |
137 | Hyperlipoproteinemia (HP:0010980) | 1.85444581 |
138 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.84133529 |
139 | Peripheral demyelination (HP:0011096) | 1.83738831 |
140 | Epidermoid cyst (HP:0200040) | 1.83415099 |
141 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83042525 |
142 | Distal arthrogryposis (HP:0005684) | 1.81224558 |
143 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.78969463 |
144 | Hypercholesterolemia (HP:0003124) | 1.77670976 |
145 | Esophageal varix (HP:0002040) | 1.77642999 |
146 | Sepsis (HP:0100806) | 1.76648218 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 4.34789243 |
2 | BLK | 4.09507316 |
3 | MAP3K14 | 3.44291441 |
4 | IRAK4 | 3.24974062 |
5 | PBK | 3.23440345 |
6 | TBK1 | 2.99058113 |
7 | EPHB1 | 2.82029884 |
8 | TYK2 | 2.60349316 |
9 | ERN1 | 2.51537241 |
10 | MAP4K1 | 2.27192515 |
11 | TTN | 2.14430760 |
12 | MAP3K13 | 2.11685708 |
13 | IKBKE | 2.05937110 |
14 | TAOK2 | 1.95921090 |
15 | TAOK3 | 1.94745709 |
16 | IKBKB | 1.80826214 |
17 | KSR2 | 1.77096468 |
18 | IRAK3 | 1.74042233 |
19 | JAK1 | 1.65674105 |
20 | NME2 | 1.61221336 |
21 | PRPF4B | 1.60676721 |
22 | TXK | 1.59957306 |
23 | KIT | 1.50117471 |
24 | BMX | 1.49705760 |
25 | OBSCN | 1.44476714 |
26 | CSK | 1.39339932 |
27 | MAP2K3 | 1.35410630 |
28 | JAK3 | 1.35099483 |
29 | TAOK1 | 1.33527860 |
30 | TRPM7 | 1.32656634 |
31 | ARAF | 1.31730913 |
32 | PIK3CG | 1.28353011 |
33 | LIMK1 | 1.23518427 |
34 | STK10 | 1.22478603 |
35 | BMPR2 | 1.21355927 |
36 | MARK3 | 1.19676646 |
37 | ABL2 | 1.16908388 |
38 | FGR | 1.16712039 |
39 | JAK2 | 1.14974491 |
40 | ADRBK2 | 1.14462507 |
41 | HCK | 1.12516769 |
42 | ACVR1B | 1.11156578 |
43 | TNK2 | 1.10732952 |
44 | BTK | 1.06070970 |
45 | TGFBR2 | 1.03808695 |
46 | DDR2 | 1.03728584 |
47 | TESK1 | 1.03717024 |
48 | MST1R | 1.02391271 |
49 | SYK | 0.98895412 |
50 | PIM2 | 0.97018197 |
51 | MUSK | 0.96409908 |
52 | FGFR4 | 0.95573393 |
53 | FES | 0.95427608 |
54 | ZAP70 | 0.93488965 |
55 | ERBB4 | 0.92901280 |
56 | TESK2 | 0.91550004 |
57 | LYN | 0.90415803 |
58 | CSF1R | 0.88393533 |
59 | MATK | 0.88200472 |
60 | NEK9 | 0.86712369 |
61 | MAP2K6 | 0.86459648 |
62 | IRAK2 | 0.80523866 |
63 | SIK1 | 0.78950423 |
64 | SIK3 | 0.78630796 |
65 | EPHA3 | 0.78426797 |
66 | MAP3K9 | 0.77797934 |
67 | LCK | 0.77191575 |
68 | CDC42BPA | 0.76967284 |
69 | MOS | 0.76342682 |
70 | STK4 | 0.75031554 |
71 | MAP3K5 | 0.70145063 |
72 | MAP3K11 | 0.69965427 |
73 | CHUK | 0.69922058 |
74 | PIM1 | 0.69494969 |
75 | TEC | 0.69264770 |
76 | MAP3K3 | 0.68001011 |
77 | MAP3K1 | 0.67350956 |
78 | PRKCD | 0.64611453 |
79 | PDPK1 | 0.64197801 |
80 | PKN1 | 0.59905785 |
81 | MST4 | 0.57904290 |
82 | ABL1 | 0.56787959 |
83 | PTK6 | 0.55079717 |
84 | PTK2B | 0.54865132 |
85 | PRKCQ | 0.53907765 |
86 | MAP3K2 | 0.49690618 |
87 | RAF1 | 0.49672090 |
88 | DAPK2 | 0.48233485 |
89 | LRRK2 | 0.47457454 |
90 | PHKG1 | 0.46314913 |
91 | PHKG2 | 0.46314913 |
92 | PDK1 | 0.44814995 |
93 | EGFR | 0.44588522 |
94 | GRK7 | 0.44444898 |
95 | RIPK1 | 0.43977378 |
96 | PRKAA2 | 0.43557594 |
97 | MAPK4 | 0.42752413 |
98 | ITK | 0.41911368 |
99 | GRK6 | 0.41459462 |
100 | PRKG2 | 0.40476615 |
101 | FYN | 0.37705291 |
102 | YES1 | 0.37006452 |
103 | CAMKK2 | 0.36131823 |
104 | CLK1 | 0.36122848 |
105 | MET | 0.35978752 |
106 | HIPK2 | 0.35970623 |
107 | MAP3K12 | 0.33183423 |
108 | RPS6KA6 | 0.32378697 |
109 | PAK1 | 0.32238163 |
110 | MAP3K7 | 0.31991960 |
111 | PINK1 | 0.31530196 |
112 | MAPK12 | 0.31459271 |
113 | CDK6 | 0.31342728 |
114 | MAPKAPK2 | 0.29865405 |
115 | BCKDK | 0.29305938 |
116 | RPS6KC1 | 0.27816909 |
117 | RPS6KL1 | 0.27816909 |
118 | GSK3A | 0.26838333 |
119 | IRAK1 | 0.25885255 |
120 | MAP3K6 | 0.25501641 |
121 | MAP2K1 | 0.24389167 |
122 | GRK5 | 0.23561813 |
123 | KDR | 0.22974384 |
124 | EIF2AK1 | 0.22152320 |
125 | PDGFRB | 0.17837664 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.74126417 |
2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.70895361 |
3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.09010662 |
4 | Legionellosis_Homo sapiens_hsa05134 | 2.40155326 |
5 | Pertussis_Homo sapiens_hsa05133 | 2.18696782 |
6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.14329468 |
7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.07892349 |
8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.02351500 |
9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.94069017 |
10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.89364818 |
11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.89301132 |
12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.88230312 |
13 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.85885993 |
14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.84596200 |
15 | Tuberculosis_Homo sapiens_hsa05152 | 1.77022602 |
16 | Malaria_Homo sapiens_hsa05144 | 1.74292791 |
17 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.69667991 |
18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.68318452 |
19 | Platelet activation_Homo sapiens_hsa04611 | 1.66690632 |
20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.65353100 |
21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.60282425 |
22 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.59020429 |
23 | Phagosome_Homo sapiens_hsa04145 | 1.56809294 |
24 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.56690415 |
25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.54605090 |
26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.51494567 |
27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.50977169 |
28 | Asthma_Homo sapiens_hsa05310 | 1.49399826 |
29 | Salmonella infection_Homo sapiens_hsa05132 | 1.45894160 |
30 | Lysosome_Homo sapiens_hsa04142 | 1.44694361 |
31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.43274367 |
32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.38326945 |
33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38139503 |
34 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.38126763 |
35 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.29207657 |
36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.26946264 |
37 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.21657394 |
38 | Allograft rejection_Homo sapiens_hsa05330 | 1.20741037 |
39 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.14115607 |
40 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.11797739 |
41 | Peroxisome_Homo sapiens_hsa04146 | 1.09153588 |
42 | Influenza A_Homo sapiens_hsa05164 | 1.08908727 |
43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.03658821 |
44 | Measles_Homo sapiens_hsa05162 | 1.01583740 |
45 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.99331466 |
46 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.98439762 |
47 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.96440543 |
48 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.95537058 |
49 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.93937884 |
50 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.93311591 |
51 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.92463717 |
52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92201330 |
53 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.91758440 |
54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91563590 |
55 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.91450941 |
56 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.91029493 |
57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.88366943 |
58 | Other glycan degradation_Homo sapiens_hsa00511 | 0.87188932 |
59 | Shigellosis_Homo sapiens_hsa05131 | 0.86466865 |
60 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.85295464 |
61 | Apoptosis_Homo sapiens_hsa04210 | 0.82587403 |
62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.82446567 |
63 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81973503 |
64 | Amoebiasis_Homo sapiens_hsa05146 | 0.81584876 |
65 | ABC transporters_Homo sapiens_hsa02010 | 0.81024980 |
66 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.80767835 |
67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80497626 |
68 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.78488706 |
69 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.74444621 |
70 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.73016975 |
71 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.71703828 |
72 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70164801 |
73 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.69668344 |
74 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.69208815 |
75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68952928 |
76 | Hepatitis C_Homo sapiens_hsa05160 | 0.68138836 |
77 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.67988977 |
78 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.67544837 |
79 | Bladder cancer_Homo sapiens_hsa05219 | 0.66197994 |
80 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66083921 |
81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64686140 |
82 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62857081 |
83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62250093 |
84 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.61943028 |
85 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61478147 |
86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.60878162 |
87 | Insulin resistance_Homo sapiens_hsa04931 | 0.60317644 |
88 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.60187741 |
89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.58915234 |
90 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58892967 |
91 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.57670754 |
92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56075501 |
93 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.55974892 |
94 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.55863350 |
95 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.55518520 |
96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.55258818 |
97 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55250608 |
98 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54705216 |
99 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54113542 |
100 | Prion diseases_Homo sapiens_hsa05020 | 0.53610482 |
101 | Mineral absorption_Homo sapiens_hsa04978 | 0.52344575 |
102 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52200570 |
103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.52123018 |
104 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.48935288 |
105 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.48481213 |
106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48174939 |
107 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.47942309 |
108 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47827693 |
109 | Viral myocarditis_Homo sapiens_hsa05416 | 0.46219563 |
110 | Endocytosis_Homo sapiens_hsa04144 | 0.43774795 |
111 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43419050 |
112 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.42377417 |
113 | Hepatitis B_Homo sapiens_hsa05161 | 0.41327417 |
114 | Retinol metabolism_Homo sapiens_hsa00830 | 0.41008795 |
115 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.40908587 |
116 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.40722942 |
117 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39314681 |
118 | Bile secretion_Homo sapiens_hsa04976 | 0.38917994 |
119 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.37436114 |
120 | Carbon metabolism_Homo sapiens_hsa01200 | 0.37101656 |
121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.36958998 |
122 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.36392456 |
123 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.35628639 |
124 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.35175354 |
125 | HTLV-I infection_Homo sapiens_hsa05166 | 0.31944673 |
126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.30957090 |
127 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.30835478 |
128 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.28752552 |
129 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.28654916 |
130 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.28400318 |
131 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.26768258 |
132 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24225987 |
133 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.23202223 |
134 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.22873732 |
135 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.21155272 |
136 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.15257352 |
137 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.14574172 |
138 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.11396722 |
139 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.10804267 |
140 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.10309278 |